BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 19278608)

  • 1. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
    Kraemer PC; Borre M
    Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
    Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
    J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endoluminal therapy for bilateral malignant ureteric obstruction].
    Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External-internal nephro-uretero-ileal stents in patients with an ileal conduit: long-term results.
    Tal R; Bachar GN; Baniel J; Belenky A
    Urology; 2004 Mar; 63(3):438-41. PubMed ID: 15028433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
    Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Success and failure with double J ureteral stent. Analysis of 107 cases].
    Tschada R; Mickisch G; Rassweiler J; Knebel L; Alken P
    J Urol (Paris); 1991; 97(2):93-7. PubMed ID: 2071929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
    Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
    J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
    Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
    AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Internal urinary derivation using an antegrade approach: indications, technic and results].
    Montserrat Orri V; Tamargo Fernández E; Gutiérrez Sanz-Gadea C; Conté Visus A; Mus Malleu A; de Miguel Sebastián P; Ozonas Moragues M
    Arch Esp Urol; 1990 Mar; 43(2):169-73. PubMed ID: 2363581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive uropathy in gynecologic malignancy. Detrimental effect of intraureteral stent placement and value of percutaneous nephrostomy.
    Hyppolite JC; Daniels ID; Friedman EA
    ASAIO J; 1995; 41(3):M318-23. PubMed ID: 8573816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Internal urinary diversion in pelvic cancers and quality of life. Value of double "J" endoprosthesis].
    Giannakopoulos X; Gartzios A; Giannakis D; Tsamboulas K; Kotoulas K
    J Urol (Paris); 1995; 101(5-6):221-7. PubMed ID: 8761875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of transurethral resection in cancer of the prostate].
    Rodríguez JV; Chechile G
    Arch Esp Urol; 1989; 42 Suppl 2():165-77. PubMed ID: 2639620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Palliative diversion using an autostatic ureteral stent after endoscopic resection of the ureteral meatus in T4 pelvic tumors].
    Flam T; Géraud M; Zerbib M; Debré B; Steg A
    Ann Urol (Paris); 1990; 24(6):530-2. PubMed ID: 1702963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome analysis and cost comparison between externalized pyeloureteral and standard stents in 470 consecutive open pyeloplasties.
    Braga LH; Lorenzo AJ; Farhat WA; Bägli DJ; Khoury AE; Pippi Salle JL
    J Urol; 2008 Oct; 180(4 Suppl):1693-8; discussion1698-9. PubMed ID: 18708220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.